Advance your academic career, collaborate globally, and expand your network— join now !

Prof. Dr. Jacobus F. Meis

Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina ...

Share Link

Share

Information

Jacques F. Meis is a consultant in Medical Microbiology and Infectious Diseases at Canisius Wilhelmina Hospital and an honorary consultant at Radboud University Medical Center in Nijmegen, The Netherlands. He received his Bachelor’s, Master’s, and Doctoratal degrees from the Faculty of Science, University of Nijmegen, and his medical degree from the University of Nijmegen Medical School in Nijmegen, The Netherlands. He completed his fellowship in the Department of Medical Microbiology at University Hospital Nijmegen, The Netherlands, where he worked as an Associate Professor until 2000. Among his clinical and laboratory interests are the treatment of fungal infections in intensive care patients and other compromised patients, in vitro activities of antifungals against filamentous fungi, and molecular typing of fungi. He was the previous president of the Dutch Society for Medical Mycology and European Confederation of Medical Mycology and was elected as a fellow of the Infectious Diseases Society of America, the Royal College of Pathologists and the American Academy of Microbiology. At present, he serves as the vice-president of ISHAM.

Research Keywords & Expertise

Candida
Resistance
Aspergillus
fungus
mycosis

Fingerprints

35%
Resistance
25%
Candida
23%
Aspergillus
7%
fungus
5%
mycosis

Short Biography

Jacques F. Meis is a consultant in Medical Microbiology and Infectious Diseases at Canisius Wilhelmina Hospital and an honorary consultant at Radboud University Medical Center in Nijmegen, The Netherlands. He received his Bachelor’s, Master’s, and Doctoratal degrees from the Faculty of Science, University of Nijmegen, and his medical degree from the University of Nijmegen Medical School in Nijmegen, The Netherlands. He completed his fellowship in the Department of Medical Microbiology at University Hospital Nijmegen, The Netherlands, where he worked as an Associate Professor until 2000. Among his clinical and laboratory interests are the treatment of fungal infections in intensive care patients and other compromised patients, in vitro activities of antifungals against filamentous fungi, and molecular typing of fungi. He was the previous president of the Dutch Society for Medical Mycology and European Confederation of Medical Mycology and was elected as a fellow of the Infectious Diseases Society of America, the Royal College of Pathologists and the American Academy of Microbiology. At present, he serves as the vice-president of ISHAM.